Monitor whether a quorum is achieved at the March 13 reconvened meeting, as repeated adjournments may signal shareholder disengagement or governance concerns, particularly for a small-cap company like iSpecimen ($29M market cap).
Price Chart
Executive Summary
iSpecimen Inc. filed an amendment to its proxy statement to reflect the resignation of director Siyun Yang, who is no longer a nominee for election at the 2025 Annual Meeting. The meeting has been repeatedly adjourned due to lack of quorum and is now set for March 13, 2026.
Key Facts
- Siyun Yang resigned from iSpecimen's Board of Directors effective February 17, 2026.
- She is no longer a nominee for election at the 2025 Annual Meeting of Stockholders.
- The Annual Meeting was originally convened on December 31, 2025, and has been adjourned multiple times due to lack of quorum.
- The meeting is now scheduled to reconvene on March 13, 2026, at 9:00 a.m. Eastern Time.
- The record date for the meeting remains November 3, 2025.
- This filing is an amendment to update proxy materials; no other changes were made to the original proxy statement.
Financial Impact
No direct financial impact disclosed.
Risk Factors
- Persistent inability to achieve quorum could delay critical governance matters or signal low investor engagement.
- Resignation of a board member without replacement may raise questions about board stability or oversight capacity.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001213900-26-023026 |
| Document: 0001213900-26-023026-index-headers.html | 0001213900-26-023026 |
| Document: 0001213900-26-023026-index.html | 0001213900-26-023026 |
| Document: 0001213900-26-023026.txt | 0001213900-26-023026 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 10, 2026 6w ago | 8-K | $1.47 | awaiting T+60 | — | $0.8721 (+40.67%) |
Sep 4, 2026 7w ago | 8-K | $1.59 | awaiting T+60 | — | $0.8721 (−45.15%) |
Aug 14, 2026 10w ago | 8-K | $2.15 | awaiting T+60 | — | $0.8721 (+59.44%) |
Aug 7, 2026 11w ago | 8-K | $2.24 | awaiting T+60 | — | $0.8721 (+61.07%) |
Aug 7, 2026 11w ago | 424B4 | $2.22 | awaiting T+60 | — | $0.8721 (+60.72%) |
Jul 31, 2026 12w ago | EFFECT | $1.89 $0.8398 | ▲ +55.57% | ▲ +58.02% | $0.8721 (+53.86%) |
Jul 16, 2026 14w ago | S-1/A | $2.10 $1.08 | ▲ +48.57% | ▲ +53.25% | $0.8721 (+58.47%) |
Jul 14, 2026 15w ago | 8-K | $2.23 $1.09 | ▼ −51.12% | ▼ −53.65% | $0.8721 (−60.89%) |
Jun 18, 2026 18w ago | EFFECT | $2.59 $1.47 | ▲ +43.24% | ▲ +45.14% | $0.8721 (+66.33%) |
Jun 1, 2026 21w ago | 8-K | $3.07 $1.64 | ▲ +46.58% | ▲ +47.70% | $0.8721 (+71.59%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers